Principal Scientist, MilliporeSigma, A business of Merck KGaA, Darmstadt, DE

Dr. Qingzhou Ji is a Principal Scientist at MilliporeSigma. He currently leads an R&D team focused on improving the genome & epigenome editing technologies, primarily the CRISPR platform. He joined Sigma-Aldrich in 2010, focusing on the areas of gene regulation and epigenetics. Qingzhou obtained his PhD in Biochemistry and Molecular Biology from Peking University. Prior to joining Sigma-Aldrich, He was a postdoctoral fellow at The Howard Hughes Medical Institute and Albert Einstein College of Medicine, where he had worked in the areas of cell biology, molecular biology, cancer research and immunology. 

MORE INFO

MilliporeSigma website

Speaker at
28-29 JANUARY 2016, GHENT, BELGIUM
Talk videos
Available for attendees of the conference